Brevital Sodium and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Brevital Sodium (methohexital).
Methohexital Alcohol (Ethanol)
Major Drug Interaction
GENERALLY AVOID: Concurrent acute use of barbiturates and ethanol may result in additive CNS effects, including impaired coordination, sedation, and death. Tolerance of these agents may occur with chronic use. The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.
MANAGEMENT: The combination of ethanol and barbiturates should be avoided.
References (5)
- Gupta RC, Kofoed J (1966) "Toxological statistics for barbiturates, other sedatives, and tranquilizers in Ontario: a 10-year survey." Can Med Assoc J, 94, p. 863-5
- Misra PS, Lefevre A, Ishii H, Rubin E, Lieber CS (1971) "Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats." Am J Med, 51, p. 346-51
- Saario I, Linnoila M (1976) "Effect of subacute treatment with hypnotics, alone or in combination with alcohol, on psychomotor skills related to driving." Acta Pharmacol Toxicol (Copenh), 38, p. 382-92
- Stead AH, Moffat AC (1983) "Quantification of the interaction between barbiturates and alcohol and interpretation of fatal blood concentrations." Hum Toxicol, 2, p. 5-14
- Seixas FA (1979) "Drug/alcohol interactions: avert potential dangers." Geriatrics, 34, p. 89-102
Switch to consumer interaction data
Brevital Sodium drug interactions
There are 291 drug interactions with Brevital Sodium (methohexital).
Report options
More about Brevital Sodium (methohexital)
- Brevital Sodium consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: general anesthetics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Dilaudid
Dilaudid (hydromorphone) is a narcotic pain reliever used to treat moderate to severe pain ...
Levsin
Levsin is used to treat stomach problems such as cramps and irritable bowel syndrome and conditions ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Duragesic
Duragesic skin patch is used to treat moderate to severe chronic pain. Learn about side effects ...
Stadol
Stadol is used for anesthesia, anesthetic adjunct, labor pain, pain
Sublimaze
Sublimaze is used for anesthesia, anesthetic adjunct, chronic pain, pain, postoperative pain, sedation
Butorphanol
Butorphanol systemic is used for anesthesia, anesthetic adjunct, labor pain, pain
Benzocaine topical
Benzocaine topical is used for anal itching, anesthesia, aphthous ulcer, burns, external, cold ...
Fentanyl
Fentanyl is an opioid medicine used to treat moderate to severe pain, but it can be misused, abused ...
Glycopyrrolate
Glycopyrrolate systemic is used for anesthesia, COPD, Maintenance, excessive salivation, peptic ulcer
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.